Você procurou por: difficile (Maltês - Inglês)

difficile colitis
vulvovaginal

kolite bi clostridium difficile
clostridium difficile colitis

mard assoċjat ma’ clostridium difficile
clostridium difficile-associated disease

kolite (inkluż clostridium difficile)
colitis (inc clostridium difficile)*

dijarea assoċjata ma' clostridium difficile
clostridium difficile-associated diarrhoea

mhux komuni: pożittiv għat- tossina tal-clostridium difficile
uncommon: positive clostridium difficile toxin

mhux komuni: kolite c. difficile (ara sezzjoni 4.4)
uncommon: c. difficile colitis (see section 4.4)

candida, enterococci u clostridium difficile (ara sezzjoni 4. 4).
candida, enterococci and clostridium difficile (see section 4.4).

l-ispeċi clostridium (ħlief c. difficile)* l-ispeċi eubacterium
clostridium species (excluding c. difficile)* eubacterium species*

- infjammazzjoni tal- musrana bid- dijarea (kolite bi clostridium difficile)
- inflammation of the bowel with diarrhoea (clostridium difficile colitis)

fidaxomicin huwa mediċina bi spettru antimikrobijali dejjaq, b’attività batteriċidjali kontra c. difficile.
fidaxomicin is a narrow spectrum antimicrobial drug with bactericidal activity against c. difficile.

tossina tal - clostridium difficile pożittiva anafilassi li tinkludi reazzjonijiet anafilattojdi tibdil fl- istatus mentali alluċinazzjonijiet
anaphylaxis including anaphylactoid reactions

għandu jiġi kkunsidrat jekk għandhiex titwaqqaf it-terapija b’invanz u jekk għandhiex tingħata kura speċifika għal clostridium difficile.
discontinuation of therapy with invanz and the administration of specific treatment for clostridium difficile should be considered.

infezzjoni mikotika vulvovaġinali, infezzjoni fil-passaġġ urinarju, infezzjoni fungali, kolite kkawżata mnn clostridium difficile, kandidjasi orali
vulvovaginal mycotic infection, urinary tract infection, fungal infection, clostridium difficile colitis, oral candidiasis

kandidajasi inkluż orofarinġali u vulvovaġinali, kolite bi clostridium difficile, infezzjoni bil-fungu fl-apparat tal- awrina
candidiasis including oropharyngeal and vulvovaginal, clostridium difficile colitis, fungal urinary tract infection

kienet irrappurtata dijarea assoċjata ma’ clostridium difficile (cdad) bi cubicin (ara sezzjoni 4.8).
clostridium difficile-associated diarrhoea (cdad) has been reported with cubicin (see section 4.8).

speċi li għalihom ir- reżistenza tista ’ tkun problema speċi acinetobacter speċi citrobacter speċi enterobacter morganella morganii reżistenti bacteroides fragilis clostridium difficile enterococci listeria monocytogenes proteus vulgaris speċi pseudomonas speċi serratia
species for which resistance may be a problem acinetobacter species citrobacter species enterobacter species morganella morganii resistant bacteroides fragilis clostridium difficile enterococci listeria monocytogenes proteus vulgaris pseudomonas species serratia species

okkorrenzi ta’ enterokolite, li jinkludu kolite newtropenika, inflammazzjoni tal-musrana l-gġamja u kolite minn c. difficile ġew irrappurtati matul kura bi clofarabine.
occurrences of enterocolitis, including neutropaenic colitis, caecitis, and c. difficile colitis have been reported during treatment with clofarabine.

bacteroides fragilis u speċi fil- grupp b. fragilis * l- ispeċi clostridium (ħlief c. difficile) * l- ispeċi eubacterium * l- ispeċi fusobacterium * l- ispeċi peptostreptococcus * porphyromonas asaccharolytica * l- ispeċi prevotella * speċi li għalihom ir- reżistenza akkwistata tista 'tkun problema:
bacteroides fragilis and species in the b. fragilis group* clostridium species (excluding c. difficile)* eubacterium species* fusobacterium species* peptostreptococcus species* porphyromonas asaccharolytica* prevotella species* species for which acquired resistance may be a problem: